A detailed history of Nordea Investment Management Ab transactions in United Therapeutics Corp stock. As of the latest transaction made, Nordea Investment Management Ab holds 78,842 shares of UTHR stock, worth $29.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
78,842
Previous 268,516 70.64%
Holding current value
$29.1 Million
Previous $85.5 Million 66.97%
% of portfolio
0.03%
Previous 0.1%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$311.04 - $363.55 $59 Million - $69 Million
-189,674 Reduced 70.64%
78,842 $28.3 Million
Q2 2024

Aug 08, 2024

SELL
$228.26 - $319.04 $7.4 Million - $10.3 Million
-32,404 Reduced 10.77%
268,516 $85.5 Million
Q1 2024

May 02, 2024

BUY
$210.76 - $249.51 $55.3 Million - $65.4 Million
262,222 Added 677.61%
300,920 $69.1 Million
Q4 2023

Jan 10, 2024

BUY
$214.88 - $256.94 $5.06 Million - $6.05 Million
23,532 Added 155.16%
38,698 $8.51 Million
Q3 2023

Nov 13, 2023

BUY
$211.82 - $248.24 $2.66 Million - $3.12 Million
12,553 Added 480.41%
15,166 $3.43 Million
Q1 2023

Apr 19, 2023

BUY
$212.99 - $276.17 $556,542 - $721,632
2,613 New
2,613 $585,000
Q2 2019

Aug 14, 2019

SELL
$76.06 - $120.81 $84,654 - $134,461
-1,113 Closed
0 $0
Q1 2019

May 20, 2019

SELL
$107.15 - $126.84 $1.14 Million - $1.34 Million
-10,600 Reduced 90.5%
1,113 $130,000
Q3 2018

Nov 14, 2018

SELL
$113.81 - $129.46 $524,095 - $596,163
-4,605 Reduced 28.22%
11,713 $1.5 Million
Q2 2018

Aug 13, 2018

BUY
$101.14 - $118.31 $465,749 - $544,817
4,605 Added 39.32%
16,318 $1.85 Million
Q1 2018

May 14, 2018

BUY
$107.21 - $151.94 $1.14 Million - $1.61 Million
10,600 Added 952.38%
11,713 $1.32 Million
Q3 2017

Nov 09, 2017

BUY
$114.6 - $136.81 $127,549 - $152,269
1,113
1,113 $130,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.8B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.